Maynard Um
-
-
-
-
-
-
-
Autolus Therapeutics (AUTL) Tops Q2 EPS by 5c
-
-
-
-
-
-
-
Agilent Technologies (A) xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
-
-
-
-
-
-
-
Autolus Therapeutics (AUTL) Appoints Matthias Will as Chief Development Officer
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

